Notes / Company

Anthem Biosciences Ltd.

ANTHEM BSE 544449 ISIN INE0CZ201020 CDMO

Fundamentals

Market cap: ₹42,899 cr
P/E: 72.49×
ROE: 18.73%
Debt / equity: 0.05
Div yield: 0.26%
52-week range: 579.15 — 873.50

Research on Tijori Finance

Company snapshot

Anthem Biosciences Ltd.

CDMO

₹42,882 cr

P/E 72.46×

Latest quarter · Mar 2026

Sales₹611 cr

Net profit₹190 cr

Op. margin+43.7%

EPS₹3.38

Strength & growth

Debt / equity0.05×

Current ratio3.91×

The timeline — 2 notes on Anthem Biosciences Ltd.

June 2026

19 Jun 26 · 3:13 PM IST Lead

Lead · Large cap

Anthem Biosciences promoter group member sells entire 3.05% stake

Aruna Ganesh sold her full 1,71,14,604 shares on June 18, 2026. The ₹44,771 cr CDMO now has one fewer direct promoter holder.

May 2026

22 May 26 · 3:45 PM IST Brief

Brief · Earnings · Large cap

Anthem Biosciences bets ₹1,200 cr on GLP-1 plant expansion

Management is doubling custom synthesis capacity to chase Indian GLP-1 demand after posting record quarterly revenue of ₹611 cr.

Verify on exchange BSE filings for ANTHEM NSE filings for ANTHEM Tijori Finance company page